Please try another search
FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Ziglim Plus 2, Vitcofol, Pyrimon DF, Zocon, Zoxan, Zathrin, Zipod, Amodep-AT, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the Electral, Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl, and Zefrich brands. In addition, it provides various active pharmaceutical ingredients. The company was founded in 1936 and is headquartered in Mumbai, India.
Name | Age | Since | Title |
---|---|---|---|
Nandan Mohan Chandavarkar | - | 2004 | Joint MD & Executive Director |
Swati Sandesh Mayekar | 65 | 2014 | Independent & Non Executive Director |
Ameya Ashok Chandavarkar | - | 2002 | CEO of International Business & Executive Director |
Ashok Anand Chandavarkar | - | 2009 | Whole Time Director |
Mohan Anand Chandavarkar | - | 2004 | BR Head, MD & Director |
Uday Kumar Gurkar | - | 2016 | Non-Executive Independent Chairman of the Board |
Nomita Ramdas Chandavarkar | - | 2014 | Non-Executive & Non-Independent Director |
Mahesh Chandru Bijlani | - | 2019 | Non-Executive & Independent Director |
Vijay Suresh Maniar | - | 2022 | Non-Executive Independent Director |
Vijay Nautamlal Bhatt | 65 | 2023 | Non-Executive & Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review